• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

Transcatheter aortic valve replacement provides only minor benefit to quality of life

bySai FolmsbeeandAimme Li, MD
February 21, 2014
in Cardiology, Chronic Disease, Surgery
Reading Time: 3 mins read
Transcatheter aortic valve replacement provides only minor benefit to quality of life
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD/CDC/Aortic Stenosis

1. According to this systemic review, transcatheter aortic valve replacement (TAVR) is associated with a decrease in New York Heart Association (NYHA) functional class, but only a minor improvement in quality of life (QOL).   

Evidence Rating Level: 1 (Excellent) 

Study Rundown: Surgical aortic valve replacement (SAVR) is the gold standard for treatment of symptomatic aortic stenosis (AS), and has been shown to both decrease mortality and improve quality of life.  Recently transcatheter aortic valve replacement (TAVR) has become an alternative for patients who are not surgical candidates.  TAVR has been shown to have comparable mortality benefit to SAVR.  However, the benefit of TAVR on quality of life (QOL) and functional status is still in question.  This systematic review looked at the effects of TAVR on the clinical markers of disease and QOL.  The reviewed studies showed a trend in decreasing in New York Heart Association (NYHA) class among those patients treated with TAVR, although many individual studies showed only a mild improvement when compared to conservative treatment. TAVR patients only showed a minor improvement in QOL, with a modest reduction as measured by Short Form 12/36 Health survey physical component summary (SF-PCS), and an even smaller change in mental component summary (MCS) scores. Furthermore, most of the studies included did not have independent comparison group receiving an alternative treatment, which may result in an overestimation of improvement from TAVR. The main limitation of this study is the heterogeneity in the studies selected, as well as the few number of total studies reviewed.

Click to read the study, in the Annals of Internal Medicine

Relevant Reading: Quality of life among patients with severe aortic stenosis

RELATED REPORTS

In At-Risk Patients With Moderate Aortic Stenosis, TAVR Reduced 2-Year Death or Heart-Failure Events

Routine postdilation improves transcatheter heart valve geometry in patients with severe aortic stenosis

In-Depth [systematic review]: The authors included 60 observational studies and 2 randomized, controlled trials in their systematic review. The overall quality of the included studies was low, with a high risk of bias and many studies lacking independent conservative treatment arms and assessors of functional outcomes. Among patients given TAVR, there was an average improvement of about 1 NYHA class at all lengths of follow-up, from 6 months to 36 months, although 8 studies showed no statistically significant improvement from TAVR. Together, the decrease in NYHA class from TAVR was comparable to those who underwent SAVR. However, there were large proportions of patients who did not improve, evident in two individual studies showing 21% and 30% of patients with either no change or worsening functional status. There were also improvements of quality of life comparable to SAVR, but only slightly better than conservative treatment. The mean changes to SF-PCS scores showed improvement with TAVR, but with high heterogeneity, shown with a range of 4.9 and 26.9 points at 12 months. Changes to MCS scores were also variable, with a range of 1.0 to 8.9 points at 12 months. Among all TAVR patients, the risk of all-cause mortality and re-hospitalization remained high, with a pooled risk of 20% and 17%, respectively, at 12-23 months and 31% and 25% past 24 months. Overall, the effect of TAVR on reducing NYHA class is present but variable, but the improvement in quality of life is generally modest.

More from this author: USPTF recommends tobacco counseling for adolescents by primary care physicians Peer-delivered education through social networking increases home-based HIV testing ACP recommends weight loss and CPAP for obstructive sleep apnea Lifestyle interventions can reduce type 2 diabetes among high-risk patients Home scoring system may prevent unnecessary pharyngitis clinic visits No evidence for the cognitive side-effects of statins Household firearm accessibility increases risk of suicide and homicide

© 2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: aortic stenosisTranscatheter aortic valve replacement
Previous Post

Multiple opioid prescriptions associated with higher hospital admissions

Next Post

Smoking may not affect short-term outcomes in cranial surgery

RelatedReports

Heart catheter procedures collage: a smiling older man with a white beard and an engraved heart with a blue guidewire
Cardiology

In At-Risk Patients With Moderate Aortic Stenosis, TAVR Reduced 2-Year Death or Heart-Failure Events

November 8, 2026
Heart valve problems collage: older man in profile, an engraved three-leaflet valve and a replacement valve on a mesh frame
Cardiology

Routine postdilation improves transcatheter heart valve geometry in patients with severe aortic stenosis

November 6, 2026
Aortic valve disease collage: an engraved heart, a three-leaflet aortic valve seen from above and a replacement valve
Cardiology

Early surgical valve replacement offers survival benefit in asymptomatic, very severe aortic stenosis

April 3, 2026
Heart disease collage: an engraved anatomical heart over a ribbon with a steady ECG trace, and three ECG electrode leads
Cardiology

PCI beneficial in patients undergoing transcatheter aortic-valve implantation

August 29, 2026
Next Post

Smoking may not affect short-term outcomes in cranial surgery

Video-based behavioral intervention benefits clinical skin examinations

Video-based behavioral intervention benefits clinical skin examinations

Addition of bevacizumab fails to benefit overall survival in newly diagnosed glioblastoma [RTOG 0825 trial]

Addition of bevacizumab fails to benefit overall survival in newly diagnosed glioblastoma [RTOG 0825 trial]

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity
  • Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers
  • A 34-circular RNA blood signature predicted Alzheimer’s disease progression and improved prediction when combined with pTau217
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.